| Increased lymphocytes and their progenitors in Apom 2/2 mice. a, b, CD4 1 and CD8 1 T cells, CD19 1 B cells, monocytes (Mono.) and neutrophils (Neut.) in blood (a) or lymph (b) from wild-type (WT; white) and Apom 2/2 (blue) mice. c, LSK cells in blood of wild-type and Apom 2/2 mice. d, Stem and progenitor cell populations in bone marrow (BM) of wild-type and Apom 2/2 mice. e, Pro-, pre-, immature, and mature B-cell populations in bone marrow of wild-type and Apom 2/2 mice. f, ETPs in thymuses of wild-type and Apom 2/2 mice. g, Proliferation of progenitors in bone marrow of wild-type and Apom 2/2 mice determined by BrdU incorporation. KO, knockout. a-g, Circles indicate values from individual mice and bars represent means. Data are compiled from two (b, c, e, f) or four (a, d, g) independent experiments. h, Representative histograms of Hoechst-33342-stained LSK bone marrow cells from wild-type and Apom 2/2 mice demonstrating entry into cell cycle. Numbers above bars represent percentage of cells in S/G 2 /M phase. i, Quantification of cycling LSK, CLP and LKSca 2 cell subsets in wild-type and Apom 2/2 mice. Bars represent means 6 standard deviation (s.d.). n 5 4. Graphs are representative of at least two experiments. *P , 0.05, **P , 0.005 as compared to wild type. 3 4 2 | N A T U R E | V O L 5 2 3 | 1 6 J U L Y 2 0 1 5
Lipid mediators influence immunity in myriad ways. For example, circulating sphingosine-1-phosphate (S1P) is a key regulator of lymphocyte egress 1, 2 . Although the majority of plasma S1P is bound to apolipoprotein M (ApoM) in the high-density lipoprotein (HDL) particle 3 , the immunological functions of the ApoM-S1P complex are unknown. Here we show that ApoM-S1P is dispensable for lymphocyte trafficking yet restrains lymphopoiesis by activating the S1P 1 receptor on bone marrow lymphocyte progenitors. Mice that lacked ApoM (Apom 2/2 ) had increased proliferation of Lin 2 Sca-1 1 cKit 1 haematopoietic progenitor cells (LSKs) and common lymphoid progenitors (CLPs) in bone marrow. Pharmacological activation or genetic overexpression of S1P 1 suppressed LSK and CLP cell proliferation in vivo. ApoM was stably associated with bone marrow CLPs, which showed active S1P 1 signalling in vivo 4 . Moreover, ApoM-bound S1P, but not albumin-bound S1P, inhibited lymphopoiesis in vitro. Upon immune stimulation, Apom 2/2 mice developed more severe experimental autoimmune encephalomyelitis 5 , characterized by increased lymphocytes in the central nervous system and breakdown of the blood-brain barrier. Thus, the ApoM-S1P-S1P 1 signalling axis restrains the lymphocyte compartment and, subsequently, adaptive immune responses. Unique biological functions imparted by specific S1P chaperones could be exploited for novel therapeutic opportunities. S1P, a bioactive lysophospholipid mediator, interacts with vertebrate-specific S1P receptors to regulate various physiological functions 6 . Most cells express one or more of the G-protein-coupled S1P receptors (S1P [1] [2] [3] [4] [5] ), which mediate cellular responses such as cell migration, adhesion and survival 7 . A unique feature of this signalling system is the enrichment of the ligand, S1P, in lymph and blood compared to interstitial fluids 1, 2 . The majority (,65%) of plasma S1P is complexed with ApoM, whereas the remainder is found in the lipoprotein-free fraction, presumably associated with albumin 3 . Circulating ApoM is predominantly associated with a specific population of HDL particles (ApoM 1 HDL) 8, 9 . S1P bound to ApoM 1 HDL maintains pulmonary vascular barrier function and migration of endothelial cells in vitro 3, 10 .
Activation of the S1P 1 receptor on immune cells residing in secondary lymphoid organs and the thymus is critical for lymphocyte egress into circulation 1, 2, 11 . FTY720 (fingolimod, trade name Gilenya), the first oral treatment for relapsing-remitting multiple sclerosis, targets this pathway, inducing lymphopenia and diminishing infiltration of autoreactive lymphocytes into the central nervous system (CNS) 12 . Emerging evidence indicates that S1P 1 also regulates T-cell differentiation, including T helper 17 and T helper 1/regulatory T cell balance 13, 14 . However, the role of S1P signalling in lymphocyte development, homeostasis and activation remains unclear. Additionally, given the poor aqueous solubility of S1P, it is unknown whether chaperones impart specificity to S1P signals in lymphocytes, resulting in distinct immune responses.
We determined whether ApoM levels affected the S1P concentrations in blood and lymph, which are known to be important for lymphocyte egress. Although plasma S1P was decreased by ,60% (ref. 3) , lymph S1P concentrations were not changed in Apom 2/2 mice (Extended Data Fig. 1a ). ApoM in lymph was estimated to be approximately half of plasma levels (Extended Data Fig. 1b ). Albumin concentrations in blood and lymph were similar in wild-type and Apom 2/2 mice (Extended Data Fig. 1c ). Analysis of peripheral blood revealed a surprising increase of CD4 1 and CD8 1 T cells and CD19 1 B cells in Apom 2/2 mice (Fig. 1a ), whereas circulating monocyte and neutrophil numbers were similar. Numbers of CD4 1 , CD8 1 and CD19 1 cells were also increased in lymph ( Fig. 1b) . Lymphocytosis was not caused by a loss of endothelial-cell S1P 1 signalling, since inducible endothelial-cell-specific deletion of S1pr1 (S1P 1 ECKO) 15 did not affect blood lymphocyte numbers (Extended Data Fig. 1d ). In contrast, global knockout of S1pr1 resulted in severe lymphopenia, consistent with a requirement for S1P 1 in lymphocyte egress from secondary lymphoid organs and the thymus (Extended Data Fig. 1d) 1 . While examination of lymph nodes (brachial and inguinal) revealed similar lymphocyte numbers in Apom 2/2 mice compared to wild-type (Extended Data Fig. 2a ), thymuses of Apom 2/2 mice contained significantly more CD4 1 CD8 1 double-positive and CD4 1 or CD8 1 singlepositive cells (Extended Data Fig. 2b) . B-cell populations in spleens of Apom 2/2 mice were slightly increased but there were no differences in the T-cell populations or spleen weights (Extended Data Fig. 2c, d ). Surface expression of lymphocyte activation markers CD69 and CD62L were unchanged in the lymph nodes, thymus and spleen (Extended Data Fig. 3a -c). Administration of anti-integrin antibodies, which block lymphocyte entry into lymph nodes, had similar effects on wild-type and Apom 2/2 lymph node cell numbers (Extended Data Fig. 3d ), implying that ApoM 1 HDL is not critical for lymphocyte egress. FTY720, which induces internalization of S1P 1 , induces lymphopenia 1, 12 . In both wild-type and Apom 2/2 mice, administration of FTY720 resulted in marked lymphopenia in blood and lymph 2 h after administration, with similar retention patterns of increased CD4 1 , CD8 1 and CD19 1 cells in lymph nodes and spleen (Extended Data Fig. 4a-d ). Double-negative thymocytes were decreased whereas double-positive and single-positive cells increased in thymuses of both wild-type and Apom 2/2 mice (Extended Data Fig. 4e ). A similar degree of lymphopenia was seen using two S1P 1 -selective agonists, AUY954 and SEW2871 (Extended Data Fig. 4f , g) 16, 17 . Collectively, these data suggest that lymphocyte trafficking out of the thymus and secondary lymphoid organs into blood and lymph is not dependent on ApoM 1 HDL.
To determine the cause of lymphocytosis seen in Apom 2/2 mice, we examined haematopoietic cell populations in blood and bone marrow (Extended Data Fig. 5a -c). LSK cells, a designation encompassing several distinct haematopoietic stem and progenitor populations, were more abundant in blood and bone marrow of Apom 2/2 mice than wild-type mice (Fig. 1c ). The bone marrow of Apom 2/2 mice also contained increased numbers of CLPs (Lin 2 Flt3 1 IL7Ra 1 cKit 1 Sca1 1 ), whereas granulocyte macrophage progenitors (GMPs; LKSca-1 2 CD34 1 F c cRII/III hi ), common myeloid progenitors (CMPs; LKSca-1 2 CD34 1 F c cRII/III lo/2 ) and megakaryocyte/erythrocyte progenitors (MEPs; LKSca-1 2 CD34 2 F c cRII/III lo/2 ) were unchanged ( Fig. 1d ) [18] [19] [20] . Pre-, immature and mature B cells in the bone marrow ( Fig. 1e ) and early thymic progenitors (ETPs)/double-negative 1 cells (DN1; CD4 2 CD8 2 CD3 2 cKit 1 CD44 1 CD25 2 ) in the thymus were increased in Apom 2/2 mice ( Fig. 1f ). Although S1P may have a role in LSK recirculation from tissues to the bone marrow 19 , B-cell bone marrow egress, which is insensitive to pertussis toxin, is probably not involved in the lymphocytosis seen in Apom 2/2 mice 21 . Two and a half hours after bromodeoxyuridine (BrdU) injection, Apom 2/2 LSK cells and CLPs had significantly more BrdU incorporation compared to wild-type cells ( Fig. 1g and Extended Data Fig. 5d ). No measurable difference was detected in myeloid progenitors. Cell cycle analysis demonstrated increased fractions of LSK cells and CLPs, but not LKSca 2 cells in S/G2/M phase in Apom 2/2 bone marrow ( Fig. 1h , i) 18 . These data suggested that ApoM restrained cell cycle entry specifically in bone marrow progenitors destined for lymphoid lineages.
Genetic deletion of the cholesterol transporters ATP-binding cassette A1 (ABCA1) and ABCG1, which interact with HDL to export cellular cholesterol, results in significant increases in LSK and myeloid progenitor cells 18, 22 . ABCG1 single knockout 23 LSK and CLP cells in wild-type (WT) and Apom 2/2 bone marrow 24 h after treatment with SEW2871 (SEW). n 5 6. *P , 0.05 versus wild type; {P , 0.05 versus vehicle-treated control. b, c, LSK and CLP cells in bone marrow (b) and percentage and total number of LSK cells (c) in blood of S1pr1 OE mice and wild-type littermates. S1pr1 OE, n 5 6; wild type, n 5 7. d, BrdU incorporation by bone marrow LSK and CLP cells of wild-type and S1pr1 OE mice. e, f, ETPs (e) or blood CD4 1 , CD8 1 and CD19 1 cells (f) from wild-type and S1pr1 OE mice. S1pr1 OE, n 5 6; wild type, n 5 7. g, Immunofluorescence of ApoM (red) bound to the surface of Lin 2 Sca-1 1 (LSK and CLP) cells from wild-type or Apom 2/2 bone marrow. 49,6-Diamidino-2-phenylindole (DAPI) nuclear counterstain, blue. h, Representative histogram and quantitative median fluorescence intensity (MFI) of GFP expression by CLPs from bone marrow of S1P 1 GFP signalling (S1P1GS; green) or control (black) mice. i, Immunofluorescence of IL-7R (red) expression and GFP (green) by CLPs. DAPI nuclear counterstain, blue. j, k, Representative flow cytometry histograms of phosphorylated (p)-Stat5 (j) and p-Erk1/2 (k) in wild-type (red) and 
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receptor (SR)-B1 (ref. 24 ), a high-affinity HDL receptor, resulted in increased mature T and B cells, respectively, while not affecting their progenitors. Our findings suggested a bone marrow compartmentspecific function of ApoM 1 HDL in lymphocyte ontogeny. We next investigated whether interleukin (IL)-7, a key regulator of lymphopoiesis 20 , was influenced by ApoM-S1P signalling. IL-7 concentrations in the bone marrow (Extended Data Fig. 5e ) and CLP IL-7Ra surface expression (Extended Data Fig. 5f ) were similar in wild-type and Apom 2/2 mice. Thus, modulation of the IL-7-IL-7Ra interaction is unlikely to be responsible for ApoM-mediated suppression of lymphopoiesis.
To examine the role of S1P in progenitor proliferation regulated by ApoM 1 HDL, wild-type and Apom 2/2 mice were treated with SEW2871 and bone marrow cell BrdU incorporation was examined ( Fig. 2a ). SEW2871 treatment suppressed BrdU incorporation in Apom 2/2 LSK and CLP cells but not in their wild-type counterparts. Treatment with AUY954 or FTY720 also had similar effects (Extended Data Fig. 6a, b ), suggesting that pharmacological activation of S1P 1 on LSK and CLP cells suppresses their proliferation. We next determined LSK and CLP cell numbers in the bone marrow of mice with an inducible S1pr1 transgene (S1pr1 OE; Extended Data Fig. 7a -c) 15 . Induction of S1P 1 expression led to decreased numbers of LSK and CLP cells ( Fig. 2b ). Blood LSK cell numbers were also reduced, ruling out increased bone marrow egress of haematopoietic progenitors ( Fig. 2c ). Both LSK and CLP populations showed decreased BrdU incorporation ( Fig. 2d ). S1P 1 overexpression also resulted in decreased ETPs in the thymus ( Fig. 2e ). Mature T-and B-cell numbers in the blood were unchanged and the secondary lymphoid organs had reduced cell numbers ( Fig. 2f and Extended Data Fig. 7d-f ), suggesting increased egress of mature lymphocytes from lymphoid organs upon S1P 1 overexpression. These pharmacological and genetic data further confirm that ApoM 1 HDL signalling via bone marrow progenitor-cell S1P 1 restrains lymphopoiesis.
Real-time reverse transcription-polymerase chain reaction (RT-PCR) analysis found that S1pr1 messenger RNA is expressed by CLPs and confirmed a previous report of its expression by LSK cells (Extended Data Fig. 8a ) 19 . Immunofluorescence analysis of Lin 2 Sca-1 1 bone marrow cells from wild-type mice showed stable association of ApoM with the cell surface ( Fig. 2g ). To determine if S1P 1 is active in bone marrow progenitor cells in vivo, we used S1P 1 green fluorescent protein (GFP) signalling mice, which show a nuclear GFP signal upon receptor activation (Extended Data Fig. 8b -f) 4 , and found that CLP and LSK cells show active S1P 1 signalling ( Fig. 2h , i).
We next examined the signal transducer and activator of transcription 5 (Stat5) pathway, which is activated by IL-7R signalling and regulates lymphocyte development, proliferation and differentiation 25, 26 . Phosphoflow analysis (Extended Data Fig. 8g , h) revealed significantly increased phospho-Stat5 in Apom 2/2 CLPs compared to wild-type cells ( Fig. 2j ). Conversely, extracellular-signal-regulated kinases 1 and 2 (Erk1/2) antagonize the proliferative signals induced by Stat5 (ref. 26) . CLPs from mice lacking ApoM-S1P had significantly less phospho-Erk1/2 than wild-type CLPs (Fig. 2k ). Collectively, these data suggest that ApoM-S1P directly interacts with bone marrow lymphocyte progenitors and activates the S1P 1 /Erk pathway to restrain their proliferation.
To test whether ApoM 1 HDL modulated lymphocyte development directly, we used in vitro lymphopoiesis assays. Using Lin 2 cells from wild-type bone marrow, we observed that the generation of B220 1 cells (pre-, pro-and immature B lymphocytes) was strongly suppressed by ApoM 1 HDL but not by albumin-bound S1P (Fig. 3a, b and Extended Data Fig. 9a ). HDL from Apom 2/2 mice, which lack S1P (ApoM 2 HDL) (Extended Data Fig. 9b ), did not suppress lymphopoiesis ( Fig. 3c ). ApoM 1 HDL-mediated suppression of lymphopoiesis was blocked by pre-incubation of HDL with an anti-S1P immunoglobulin M (IgM) but not by an irrelevant IgM (Fig. 3d ). These findings suggest that ApoM 1 HDL-bound S1P is critical to restrain lymphocyte progenitor differentiation and proliferation.
To determine the involvement of S1P 1 , cultures were incubated with AUY954 or phosphorylated FTY720 (FTY720p), resulting in significantly decreased numbers of B220 1 cells ( Fig. 3e ). However, incubation of Lin 2 bone marrow cells with W146, a selective S1P 1 antagonist, abrogated the suppressive effect of ApoM 1 HDL. Next, we used Lin 2 bone marrow from S1P 1 S5A mice, which express a mutated S1P 1 that is internalization defective, resulting in extended surface residency and sustained signalling 13, 17, 27 . S1P 1 S5A bone marrow cells were more 
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175 nM ApoM-S1P 500 nM albumin-S1P Figure 3 | ApoM-S1P activation of S1P 1 suppresses lymphocyte progenitor generation in vitro. a, B220 1 cells generated from wild-type (WT) Lin 2 bone marrow after incubation with increasing concentrations of ApoM 1 HDL S1P or albumin-S1P. b, Representative flow cytometry plots of IL-7Ra 1 versus CD11b 1 cells generated in the presence of 175 nM ApoM-S1P or 500 nM albumin-S1P. c, B220 1 cell numbers generated after culture in the presence of human HDL (hHDL; 100 mg ml 21 ), or increasing concentrations of mouse ApoM 1 HDL (wild type) or ApoM 2 HDL (Apom 2/2 ). d, B220 1 cells generated after incubation with ApoM 1 HDL (50 mg ml 21 ), ApoM 1 HDL plus IgM, or ApoM 1 HDL plus anti-S1P. e, B220 1 cells generated in the presence of vehicle, AUY954 (AUY; 10 nM), FTY720p (FTY; 10 nM), 100 mg ml 21 ApoM 1 HDL, or W146 (100 nM) plus 100 mg ml 21 HDL. f, B220 1 cells generated from wild-type or S1P 1 S5A (S5A) Lin 2 bone marrow cells after incubation in the presence of increasing concentrations of ApoM 1 HDL-S1P or albumin-S1P. g, Number of B220 1 cells generated from S5A Lin 2 bone marrow incubated with increasing concentrations of ApoM 1 HDL (wild type) or ApoM 2 HDL (Apom 2/2 ). a-e, n 5 5 (a-c) or 6 (d, e); data are compiled from two independent experiments. f, g, Wild type, n 5 5; S5A, n 5 3; data are representative of two experiments. *P , 0.05, **P , 0.005, ***P , 0.001 versus control or vehicle values. {P , 0.05 versus wild-type value. Bars represent mean 6 s.d. sensitive to ApoM-S1P than wild-type bone marrow, since lower S1P concentrations were sufficient to repress B220 1 development ( Fig. 3f ). Despite greater S1P sensitivity, albumin-S1P was unable to suppress lymphopoiesis by S1P 1 S5A cells, similar to wild-type cells. ApoM 2 HDL did not suppress B220 1 generation from S1P 1 S5A bone marrow cells ( Fig. 3g ). Collectively, these findings support the hypothesis that ApoM 1 HDL activation of S1P 1 on lymphocyte progenitors inhibits their proliferation.
We hypothesized that modulation of the lymphocyte compartment size by ApoM 1 HDL could impact the magnitude of immune responses. The experimental autoimmune encephalomyelitis (EAE) model recapitulates many aspects of multiple sclerosis pathology, including increased bone marrow cell proliferative capacity, bloodbrain barrier (BBB) disruption, and autoreactive immune cell CNS infiltration 5 . Interestingly, increased plasma HDL correlates with decreased acute inflammation in multiple sclerosis patients, although the mechanism and the role of specific HDL populations are unknown 28, 29 . To ascertain whether the expanded lymphocyte compartment in Apom 2/2 mice could affect the extent and intensity of the adaptive immune response, we induced EAE in wild-type, Apom 2/2 mice, and mice overexpressing a human APOM transgene (APOM Tg ) 3 by immunization with myelin oligoglycoprotein (MOG ) peptide. Mice lacking ApoM developed symptoms earlier and exhibited more severe CNS pathology compared to wild-type mice (Fig. 4a ). Remarkably, APOM Tg mice developed milder symptoms, supporting a protective role for ApoM-S1P ( Fig. 4a ). More severe inflammation in the CNS was evident at day 16 after immunization in Apom 2/2 brains as compared to the wild-type counterparts (Fig. 4b ), and increased lymphocytes were found in Apom 2/2 brains at the peak of disease ( Fig. 4c ) Lymphocytes from MOG-immunized Apom 2/2 mice were highly activated, as demonstrated by increased splenocyte proliferative responses to ex vivo MOG restimulation ( Fig. 4d ). Thus, the increase in bone marrow proliferation of lymphocyte progenitors and increased circulating lymphocytes in Apom 2/2 mice resulted in an exaggerated autoimmune neuroinflammatory response, whereas overexpression of ApoM was protective.
Previously, our laboratory has reported that the loss of ApoM results in enhanced pulmonary vascular leakage 3 . To determine whether altered vascular barrier function was contributing to increased EAE severity, wild-type and Apom 2/2 mice were injected intravenously with tetramethylrhodamine (TMR)-labelled dextran (70 kilodalton) before or 8 days after MOG immunization to assess BBB functionality. Before immunization, no differences in dextran extravasation were evident in the brain or spinal cord (Fig. 4e , f and Extended Data Fig. 10a ). After immunization, Apom 2/2 brains and spinal cords displayed significantly increased vascular leakage. This was dependent upon the immune response, since pertussis toxin alone was insufficient to induce vascular leakage (Extended Data Fig. 10b ). Thus, the BBB was intact in mice lacking ApoM before MOG immunization, and induction of an immune response was necessary for the generation of EAE and associated BBB breakdown. S1P 1 ECKO mice have increased pulmonary vascular leakage (Extended Data Fig. 10c ); however, deletion of endothelial S1pr1 did not influence EAE disease severity ( Fig. 4g ), suggesting that alterations Day post-immunization Mean disease severity score 
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in vascular barrier function are not sufficient to modulate autoimmune responses in the CNS. Similarly, S1P 1 expression by astrocytes has been shown to affect EAE severity 30 . Since neurovascular leakage would be a necessary antecedent for plasma ApoM-S1P to gain access to astrocytes, it seems unlikely that the increased disease severity seen in Apom 2/2 mice is due to direct ApoM effects on neural cells. Collectively, these data indicate that ApoM-S1P signalling in lymphocytes is a key factor in the increased EAE pathology displayed by Apom 2/2 mice. In summary, these data reveal an unexpected mechanism by which ApoM 1 HDL specifically restrains bone marrow lymphopoiesis by inducing S1P/S1P 1 receptor signalling in bone marrow progenitors, thereby limiting the lymphocyte compartment. These findings also suggest that unique functions of S1P are imparted by its chaperone, ApoM 1 HDL, and that ApoM 1 HDL-dependent S1P/S1P 1 signalling induces distinct physiological outcomes. Although dispensable for lymphocyte trafficking, ApoM-S1P attenuation of lymphopoiesis under homeostasis may be an important regulator of the lymphocyte life cycle, and therefore have a role in autoimmune responses. Our studies indicate that ApoM 1 HDL-mediated regulation of lymphocyte ontogeny impacts the extent and intensity of autoimmune neuroinflammation in the EAE model. Furthermore, chaperone-dependent S1P signalling may allow the development of novel strategies for the control of immune responses.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper.
METHODS
Animals. Apom 2/2 and APOM Tg mice were crossed at least nine generations to the C57BL/6 genetic background 3, 31 . C57BL/6 mice purchased from Jackson Laboratory were used as wild-type controls. To generate mice that overexpress S1P 1 , mice expressing the S1p1 f/stop/f transgene were crossed to mice expressing the tamoxifen-inducible Rosa26-Cre-ER T2 to yield S1p1 f/stop/f Rosa26-Cre-ER T2 animals 15 . To generate mice with endothelial-cell-specific deletion of S1pr1, mice with floxed S1p1 genes (S1pr1 fl/fl ) were crossed with mice expressing a tamoxifen-inducible Cre under the control of the VE-cadherin gene (Cdh5-Cre-ER T2 ) 15, 32 . For both S1pr1-overexpressing mice (S1pr1 OE) and endothelial-cell-specific deletion (ECKO), Cre-negative littermates were used as controls. To induce deletion of the floxed S1p1r or floxed 'stop' sequence, mice were treated with tamoxifen by oral gavage, 4 mg every third or fifth day for a total of three treatments. S1pr1 OE mice were analysed 3-4 days after the final tamoxifen administration; ECKO mice were analysed $10 days after the final tamoxifen administration. S1P 1 GFP signalling mice were generated as previously described 4 . Briefly, mice expressing a transcriptional unit consisting of the S1P 1 carboxy terminus fused to tetracycline transcriptional activator (tTA) and b-arrestin fused to tobacco etch virus (TEV) protease knocked in to the endogenous S1P 1 locus were crossed with mice containing a histone-GFP reporter gene under the control of a tTA-responsive promoter. Mice expressing one allele of both the S1pr1Ki and the GFP alleles were considered S1P 1 GFP signalling mice. Littermates expressing only the GFP allele without the S1P 1 knock-in were considered controls. For all bone marrow studies, animals were killed and tissues collected between 12:00 and 15:00 to limit circadian effects. No randomization method was used and investigators were blinded to the genotype of animals during data analysis. The minimum number of animals per group was four and for all inducible Cre strains wild-type littermate controls were used. Male and female mice were used as age-matched controls for all studies except for EAE experiments, for which only female animals were used. No animals were excluded from the analysis. Animals were housed in a specific pathogen-free facility and provided food and water ad libitum. All animal protocols were approved by the Institutional Animcal Care and Use Committee of Weill Cornell Medical College. Verification of S1pr1 mRNA overexpression and floxed 'stop' excision. After completion of the tamoxifen treatment regimen, RNA was extracted from whole bone marrow with Trizol according to the manufacturer's instructions, and TaqMan real-time multiplex RT-PCR was performed as described later to assess overexpression of S1pr1 mRNA. For extraction of genomic DNA from the same samples, back extraction buffer (1 M Tris, pH 8.0, 4 M guanidine thiocyanate, 50 mM sodium citrate) was added to the remaining organic phase and interphase, vortexed, and incubated for 10 min at room temperature. Samples were then centrifuged at 4 uC for 15 min at 12,000g and the aqueous phase transferred to a new tube. DNA was precipitated with 400 ml isopropanol and samples centrifuged again at 4 uC for 15 min at 12,000g. Supernatant was removed, samples washed with 75% ethanol and the DNA pellet was resuspended in H 2 O. PCR was performed using 20 ng of DNA, with the following primers. 59: GTTCGGCTTCTGGCGTGTGA; 39: CCAGGTCCTCC TCGGAGATC; and the reaction conditions: 95 uC/30 s, 56 uC/30 s, 72 uC/1 min for 30 cycles. Amplification of the intact floxed stop cassette yielded a 1.4 bp fragment and, when deleted, a 308 bp fragment. Cell and plasma collection from blood and lymph. Mice were euthanized with CO 2 . Blood was recovered via terminal cardiac puncture and collected in tubes containing 35 ml 0.1 M EDTA. Five-hundred millilitres of whole blood was then removed to a new tube, centrifuged at 2,000g for 15 min, and plasma removed and stored at 220 uC. Cells were then subjected to ammonium chloride (ACK) erythrocyte lysis, washed with PBS, and stained with eFluor718 fixable viability dye (eBioscience) according to manufacturer's instructions. Lymph was recovered from the cisterna chyli, as previously described 2, 33 , and collected in 5 ml acid citrate-dextrose. Total lymph volume was recorded before the entire sample was centrifuged at 2,000g for 15 min to isolate plasma. Plasma was then removed and cells were washed with PBS before staining with the eFluor718 viability dye. After a PBS wash, blood and lymph cells were then briefly fixed for 30 min in 0.1% paraformaldehyde (PFA), washed, and stained with antibody cocktails for flow cytometry, as described later 34 . Tissue cell isolation. Single-cell suspensions were created from spleen, thymus and lymph nodes (two inguinal and brachial lymph nodes per mouse) by gently disaggregating tissue between frosted glass slides. Bone marrow cells were collected after removing the epiphyses and a brief centrifugation in a 1.5 ml tube. Cells were then washed with 1% FBS in PBS and subjected to ACK lysis buffer. After another PBS wash, cells were stained with eFluor718 viability dye. For some studies, such as cell sorting, cells were stained for and analysed by flow cytometry unfixed. Except for studies requiring live sorted cells, samples were gently fixed with 0.1% PFA for 10 min and then washed with 1% FBS in PBS, unless noted otherwise. Although absolute numbers were lower after fixation, this did not have a dramatic effect on staining patterns and gave results similar to those obtained using unfixed cells. Flow cytometry. After fixation, cells were washed with 1% FBS in PBS (flow buffer (FB)) and Fc receptors were blocked with TruStain FcX (Biolegend) in 3% FBS overnight at 4 uC. Cells were then aliquoted and stained in their respective antibody cocktails for 30 min on ice. After washing with FB, liquid counting beads (BD) were added to each sample and data were obtained on a BD LSRII (Becton Dickson) and analysed using FlowJo software (Tree Star, Inc.).
Antibodies were purchased from BioLegend (BL), eBioscience (eB), Southern Biotech (SB), or Becton Dickson (BD). For the determination of blood and lymph cell populations the following clones and antibody-fluorophore conjugates were used: CD4-PE (RM4-4, BL), CD8-PerCP/eFluor710 (H35-17.2; eB), CD19-eFluor450 (ID3; eB), CD11b-APC-eFluor780 (M1/70; eB), Ly6C-FITC (HK1.4; SB), Ly6G-PE-Cy7 (1A8; BL) and CD115-APC (AFS98; BL). For the determination of lymph node and splenocyte populations: CD4-APC-Cy7 (GK1.5; BL), CD8-eFluor450 (H35-17.2; eB), B220-AF700 (RA3-6B2; eB), CD62L-PerCP-Cy5.5 (MEL-14; BL) and CD69-PE-Cy7 (H1.2F3; eB). For the determination of thymocyte populations: CD3-APC-Cy7 or -AF700 (17A2; eB), CD4-PE (RM4-4, BL), CD8-APC (53-6.7, eB), CD62L-PerCP-Cy5.5 (MEL-14; BL), CD69-PE-Cy7 (H1.2F3; eB), CD44-AF700 or -PECy7 (IM7; eB), CD25-AF488 (3C7; eB), cKit-PerCP-eFluor710 or -APC-eFluor780 (CD117; 2B8; eB). DN1 cells (ETPs) were defined as CD4 2 CD8 2 CD3 2 CD44 1 CD25 2 cKit 1 ; DN2 cells were defined as CD4 2 CD8 2 CD3 2 CD44 1 CD25 1 ; DN3 cells were defined as CD4 2 CD8 2 CD3 2 CD44 lo/2 CD25 1 ; DN4 cells were defined as CD4 2 CD8 2 CD3 2 CD44 2 CD25 2 . For the determination of bone marrow B-cell populations: B220-AF700, cKit-APC-eFluor780, CD19-PE-Cy7, Flt3-PE, CD24-BV421, CD43-AF488, IgM-PerCP-Cy5.5, IgD-APC. Pro-B cells were defined as B220 1 cKit 1 CD19 1 Flt3 2 CD24 1 IgM 2 ; pre-B cells were defined as B220 1 cKit 2 CD19 1 Flt3 2 CD24 1 IgM 2 ; immature B cells were defined as B220 1 cKit 2 CD19 1 Flt3 2 CD24 1 IgM 1 , and mature B cells were defined as B220 1 cKit 2 CD19 1 Flt3 2 CD24 lo/2 IgM 1/2 IgD 1 . To quantify bone marrow cell populations with or without BrdU [18] [19] [20] [35] [36] [37] : Lineage (Lin) cocktail-eFluor450 (17A2, RA3-6B2, M1/70, Ter-119, RB6-8C5; eB), Flt3-PE (CD135; A2F10; eB), cKit-PerCP-eFluor710 or -APC-eFluor780 (CD117; 2B8; eB), Sca-1-PE-Cy7 (Ly6A/E; D7; eB), IL-7Ra-APC-eFluor780, -FITC, or BV421 (CD127; A7R34; eB or SB/199; BD), CD34-APC (RAM34; BD), FccRII/III-AF700 (93; eB), BrdU-PerCP-eFluor710 (BU20A; eB). For low abundance markers (cKit, Sca-1, IL-7Ra, CD34, FccRII/III, CD25 or CD44), fluorescence minus one (FMO) controls were used to set staining gates.
For S1P 1 staining, tibiae bone marrow were spun into a tube containing 35 ml EDTA, then immediately fixed with 0.1% PFA on ice for 1 h. After washing with 100 nM HEPES in PBS, nonspecific interactions were blocked with anti-CD16/32 at room temperature for 15 min. Cells were then aliquoted for anti-S1P 1 or isotype staining (R&D) overnight at 4 uC. The next day, cells were washed twice with PBS-HEPES and stained to identify bone marrow populations. Phosphoflow for phospho-Stat5 and phospho-Erk1/2. Whole bone marrow cells were resuspended in Lyse/Fix buffer (BD Biosciences) and processed according to manufacturer's instructions. To permeabilize, 100% methanol pre-cooled at 280 uC was added and cells were vortexed for 15 s before 45 min incubation on ice. After washing with 3% FBS in PBS, cells were incubated in Fc block (anti-CD16/ 32) and Innovex Biosciences peptide Fc block at room temperature for 20 min before incubation with antibody cocktails. For detection of phospho epitopes in CLPs, the following antibodies were used: Lineage cocktail-PE, cKit-PerCP-eFluor 710, Sca-1-PE-Cy7, and CD127-BV421. Anti-p-Stat5 (pY694) and p-Erk1/2 (pT202/pY204) were conjugated to AF488. As controls, splenocytes were isolated from wild-type mice and incubated with IL-7 (10 ng ml 21 ; p-Stat5) or PMA (5 ng ml 21 ; p-Erk1/2) or left unstimulated. After 15 min, Lyse/Fix buffer with 30% FBS was immediately added to cells to preserve the phosphor epitopes. Cells were then processed as described earlier for bone marrow samples. CD11b 1 cells were considered the negative control for p-Stat5 in response to IL-7 stimulation. CD19 1 cells were considered the positive controls for p-Stat5 and p-Erk1/2 (refs 34, 38) . Drug administration. FTY720 (fingolimod, trade name Gilenya) was administered orally at a single dosage of 0.5 mg kg 21 in 200 ml of 2% 2-hydroxypropyl-bcyclodextran (HbC; Sigma-Aldrich). AUY954 was dissolved in dimethylsulphoxide (DMSO) and administered orally at a single dosage of 3 mg kg 21 in 200 ml of 2% HbC. Both FTY720 and AUY954 were gifts from Novartis Pharma AG. SEW2871 (Cayman Chemical) was dissolved in 1:4 Tween-20 and ethanol, then administered twice at 0 h and 12 h at a dosage of 20 mg kg 21 orally in 200 ml of HbC before mice were killed at 24 h. For all studies, control animals were treated with the appropriate vehicle. Albumin ELISA. Albumin concentrations in blood and lymph plasmas were determined using the mouse albumin ELISA kit from Bethyl Labs, according to LETTER RESEARCH manufacturer's instructions. Blood plasma was diluted 1:1.6 3 10 6 and lymph plasma 1:8 3 10 5 before analyses. ApoM and ApoA1 immunoblots. One microlitre of mouse blood plasma was first diluted in 10 ml PBS, then diluted serially 1:1 in PBS, and 1 ml of diluted lymph plasma was further diluted in 10 ml PBS. Samples were then denatured by boiling in SDS sample buffer and separated on a 12% denaturing gel. After transfer to PVDF membrane, blots were incubated overnight at 4 uC with 1:1,000 dilution of antibodies against ApoM (rabbit anti-human; Genetex) or ApoA1 (goat anti-mouse; AbCam) in 5% milk in Tween-20 Tris-buffered saline (TBS-T). Secondary antibodies were incubated at 1:10,000 dilution in 1% TBS-T for 1 h at room temperature. For approximation of ApoM concentrations, bands for the blood plasma dilution were analysed by densitometry using ImageJ software (NIH) to create a standard curve. Undiluted blood plasma ApoM concentrations were assumed to be approximately 900 nM. Densitometric values obtained for ApoM bands from lymph plasma were compared to the standard curve and an approximate concentration calculated, which was then normalized to lymph volume. ApoA1 was used as an internal control. S1P quantitation. Bioactive sphingolipids were extracted from blood, lymph or HDL preparations by a single-phase ethyl acetate:isopropanol:water process and quantitated by electrospray ionization-tandem mass spectrometry (ESI-MS/MS) as described previously 39 . Integrin blockade. Mice were injected intraperitoneally with 100 mg of anti-integrin a4 (BD Pharmingen, clone M17/4) and 100 mg of anti-integrin aL (Millipore, clone PS/2) 40 in a total of 200 ml. Fourteen hours later, mice were killed and brachial and inguinal lymph nodes collected. A single-cell suspension was then analysed by flow cytometry. Administration and quantitation of BrdU. BrdU was solubilized in 10 mN NaOH/H 2 O. Four milligrams BrdU (Sigma) in 200 ml PBS was injected intraperitoneally into each mouse 2.5-3 h before they were killed 37, 41, 42 . Control mice were injected with 200 ml of PBS alone. For quantitation of BrdU incorporation, after isolation and red blood cell (RBC) lysis, cell suspensions were fixed in 4% paraformaldehyde (BD) at room temperature for 10 min, then washed in 5% FBS followed by PBS. Cells were permeabilized in 100 ml of 0.125% Dawn dishwashing detergent (Procter and Gamble) in 13 PBS for 15 min at room temperature, then washed twice with 1% FBS in PBS. Cells were resuspended in DNase buffer (10% FBS in 1 mM CaCl 2 and 0.1 mM MgCl 2 ) containing 150 U of DNase per sample and incubated at 37 uC for 45 min before washing twice in PBS. Samples were then resuspended in Fc blocking buffer and incubated with antibody cocktail for analysis by flow cytometry. Cell cycle analysis using Hoechst 33342 DNA incorporation. Freshly isolated cells were stained with antibody cocktail (anti-Lineage, anti-cKit and anti-Sca-1), washed, then resuspended in 10 mg ml 21 Hoechst 33342 (Life Technologies) in 13 PBS and incubated at room temperature for 45 min before fixation with 0.1% PFA and flow cytometric analysis. Bone marrow IL-7 quantitation. Complete bone marrow was collected in 5 ml 0.1 M EDTA, then gently triturated in 200 ml PBS. Cell suspensions were then centrifuged at 2,000g for 5 min at 4 uC, then supernatants were removed to a new tube and stored at 280 uC until analysis. IL-7 expression was quantified by ELISA according to the manufacturer's instructions (R&D). Multiplex quantitative real-time RT-PCR. B cells were isolated from whole spleen single-cell suspensions using the EasySep mouse CD19-positive selection kit (StemCell Technologies), followed by the EasySep mouse T-cell isolation kit for negative selection of T cells. Bone marrow from wild-type mice was subjected to negative selection for Lin 2 cells, then LSK (Lin 2 cKit 1 Sca-1 1 ) cells and CLPs (Lin Kit lo Sca lo IL-7Ra 1 Flt3 1 ) were collected by FACS. RNA was isolated using Trizol and concentrated using the RNA Clean and Concentrator kit (Zymo Research). Real-time RT and TaqMan PCR were performed using the TaqMan RNA-to C T 1-step kit (Life Technologies), and primers specific for mouse S1pr1. Reactions were normalized to expression of the housekeeping gene Nidogen within the same tube using the DD 2 Ct method 43 and data are represented as fold change compared to expression by splenic B cells. Ex vivo ApoM staining of bone marrow cells. Bone marrow was spun into a tube containing 35 ml EDTA and the femurs flushed with PBS and resuspended. Cells were fixed with 0.1% paraformaldehyde at room temperature for 30 min and washed with PBS. Non-specific interactions were first blocked by incubation with Innovex Biosciences peptide Fc block at room temperature for 15 min, then 10% fatty-acid-free bovine serum albumin, Fraction V (FAF-BSA), 5% milk and anti-CD16/32 were added to 1 ml for an additional 10 min. This was used in place of the suggested separation medium when cells were processed for lineage-negative depletion, followed by Sca-1 positive selection (both kits from StemCell Technologies). Cells were then washed twice with BSA/milk by gentle mixing, then returning them to the magnet and pouring off liquid. Two drops of peptide Fc block with anti-CD16/32 were added to each tube and incubated at room temperature for 5 mins. An aliquot of cells was set aside for staining with secondary antibody alone; the remainder was incubated with 1:200 dilution of rabbit anti-ApoM (GeneTex #62234) for 30 min at room temperature. Cells were washed on the magnetic column three times with BSA/milk before incubation with a 1:5,000 dilution of donkey anti-rabbit AF546 (Life Technologies) for 30 min at room temperature. After washing again on the magnetic column, cells were incubated in PBS containing DAPI before imaging with an Olympus Fluoview Fv10i confocal microscope using the 360 water objective. Intensities for the blue and red channel were adjusted for the Apom 2/2 cells in accordance with their spectra and, once set, the same settings were used for the wild-type images. Thus, channel intensity correction was the same for each sample and no gamma correction was used. Ex vivo IL-7Ra staining of bone marrow cells from S1P 1 GFP signalling mice. Bone marrow was spun into a tube containing 35 ml EDTA and the femurs flushed with, and resuspended in, 0.1% paraformaldehyde. Cells were fixed at room temperature for 12 min and washed with 1% FBS in PBS before being subjected to lineage depletion followed by Sca-1 positive selection. Cells were then stained with either Lin cocktail or biotinylated anti-IL-7Ra primary antibody (clone SB/199; BD) followed by streptavidin-AF596 secondary antibody (Jackson Immunoresearch). All cells were incubated in DAPI in PBS before imaging by confocal microscopy, as described earlier.
In vitro haematopoiesis and lymphopoiesis. Lineage-negative (Lin 2 ) bone marrow cells from wild-type or S5A mice were isolated using a negative selection magnetic bead kit (StemCell Technologies). In some experiments, CLPs from wild-type mice were sorted by FACS. Five-thousand cells were then incubated in 350 ml methylcellulose medium HPP-SP1 (MC; HemoGenix) containing IL-3, IL-6, stem cell factor (SCF), thrombopoietin (TPO), Flt3L, BSA and 5% FBS and supplemented with 10 ng ml 21 rmIL-7 (Peprotech). Control wells contained only this complete medium. Data from at least two duplicate wells per experimental condition were averaged. Cells from each mouse were assayed individually and not pooled. The stock solution of W146 was prepared in filtered Na 2 CO 3 buffer and sonicated until dissolved, then added to MC at a final concentration of 1 mM. AUY954 was dissolved in DMSO and diluted in MC for a final concentration of 100 nM and 0.001% DMSO. FTY720p was dissolved in 13 PBS and added to MC. The vehicle control for the in vitro agonist/antagonist studies was 0.001% DMSO. Human and mouse HDLs were isolated by ultracentrifugation of plasma from healthy donors or mice as previously described and added to MC at the concentrations indicated [44] [45] [46] . The content of S1P in HDL preparations was determined by high-performance liquid chromatography (HPLC) and LS/MS/MS as described earlier 46 . For S1P neutralization by anti-S1P antibody, 50 mg ml 21 HDL was incubated with 25 mg ml 21 of either anti-S1P antibody (Alfresa Pharma Corp) or mouse IgM (Bethyl Labs) at 37 uC for 1 h, then added to the MC 47 . Albumin-S1P was prepared by reconstituting stock S1P (in ethanol) in 0.1% fatty-acid-free BSA (FAF-BSA; Fisher), then sonicating for 20 s. Dilutions were then made in 0.1% FAF-BSA before adding to MC. All MC incubations of Lin 2 cells were incubated for 10 days at 37 uC and 5% CO 2 . Flow cytometric analysis of in vitro incubations. For cell collection, 500 ml of PBS was added to each well, incubated for 10 min, then gently triturated to resuspend the cell culture/MC mixture. Resuspended cells were removed to a 1.5 ml microcentrifuge tube and cells remaining in the well were collected with an additional 500 ml of PBS. Cells were then centrifuged at 700g for 10 min at 4 uC, washed once with PBS, then processed for incubation with antibody cocktail and flow cytometric analysis as earlier. Induction of EAE. EAE was induced by subcutaneous injection on both flanks and base of the tail of 200 mg myelin oligoglycoprotein (MOG ) peptide (Alpha Diagnostic Intl.) emulsified in 200 ml of complete Freund's adjuvant (Difco). Twohundred nanograms of Bordatella pertussis toxin (List Biological Laboratories) was injected intraperitoneally in 200 ml on the day of immunization and 48 h later 5, 13 . Clinical scores were determined based on the following scale: 0, normal; 1, tail weakness; 2, tail paralysis and hind limb weakness; 3, complete hind limb paralysis; 4, hind limb paralysis with forelimb weakness; and 5, moribund or death 13 . For histopathological analysis of brain tissue sections, brains were removed and fixed in 10% neutral-buffered formalin overnight at room temperature. After washing in PBS, brains were placed in 70% ethanol before paraffin embedding. Tissue sections were then stained with haematoxylin and eosin (Histoserve). Isolation of CNS-infiltrating immune cells. Brains from wild-type and Apom 2/2 mice were minced, then digested in a mixing incubator for 1 h at 37 uC and 1,300 r.p.m. in a cocktail of Liberase (1 U per 1 ml; Roche) and DNase (1 mg ml 21 ; Sigma) in Hank's balanced salt solution (HBSS). Tissues were further disaggregated by repeated passage through an 18G needle, then brought to 1 ml with HBSS. Leukocytes were isolated on a discontinuous Percoll gradient according to Pino and Cardona 48 and analysed by flow cytometry.
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In vitro lymphocyte restimulation. Spleens from wild-type or Apom 2/2 mice were isolated 9 days after MOG peptide immunization. After disaggregation and erythrocyte lysis with ammonium chloride, cells were cultured in 96-well plates at a density of 5 3 10 5 cells with increasing concentrations of MOG peptide. After 96 h of incubation, numbers of CD4 1 cells were quantified by flow cytometry 13 . Evans blue dye extravasation measure of vascular permeability. Pulmonary vascular leakage was measured by Evans blue dye (EBD) accumulation assay. EBD (0.5% in PBS) was injected via tail vein 90 min before tissue harvest. Pulmonary vasculature was perfused with 5 ml PBS through the right ventricle, while allowing the perfusate to drain from an incision in the left ventricle. Lungs were then weighed and dried at 56 uC overnight. Dry lung weight was measured again, and EBD was dissolved in formamide at 37 uC for 24 h and quantitated spectrophotmetrically at 620 and 740 nm. TMR-dextran brain and spinal cord vascular permeability. Eight days after MOG immunization, MOG-immunized mice, mice injected with pertussis toxin alone, or unimmunized mice were injected via tail vein with 100 ml of 25 mg ml 21 TMR-dextran in 1 mM CaCL 2 . After 18 h, mice were killed by CO 2 and perfused with approximately 10 ml PBS. Brain and spinal cord were removed and protected from light from this point. After weighing, tissues were homogenized in 1% Triton X-100 in PBS then spun at 4 uC for 25 min at 20,000g. Supernatants were transferred to new tubes until fluorometric analysis at 540/590. Statistical analyses. Statistical analyses were performed using GraphPad Prism software v.6.0. Two-tailed Student's t-test was used for direct comparison of two groups. Analysis of variance (ANOVA) followed by Dunnett's for comparison to control group or Tukey's to compare all groups was used to determine significance between three or more test groups. Differences in EAE clinical scores were determined using the Mann-Whitney U-test for analysis of the area under the curve and at individual time points. For all analyses, a was set to 0.05 and P values # 0.05 were considered significantly different. decreases in lymphocyte populations in the thymus and secondary lymphoid organs. a, Representative flow cytometry plots and quantitative MFI of S1P 1 expression by Lin 2 cells from S1pr1 OE and wild-type (WT) littermates. n 5 3. b, Relative expression levels of S1pr1 mRNA in bone marrow cells of S1pr1 OE mice relative to wild-type mice, as determined by multiplex qRT-PCR. c, Representative agarose gel of Cre activation and excision of the floxed stop cassette as assessed by PCR of genomic DNA from bone marrow cells of S1pr1 OE mice, lox/stop/lox littermate, or wild-type littermate. Arrows indicate amplified DNA fragments corresponding to undeleted or deleted segments d-f, Four days after the final dose of tamoxifen, CD4 1 , CD8 1 and CD19 1 cells in brachial and inguinal lymph nodes (d) and spleen (e), and thymic CD4 1 CD8 1 double-positive (DP), CD4 1 and CD8 1 single-positive (CD4 or CD8 SP), total double-negative (DN), and double-negative subpopulations DN2, DN3 and DN4 (f) were quantified by flow cytometry in S1pr1 OE mice and wild-type littermates. Bars represent means 6 s.d.; S1pr1 OE, n 5 6; wild type, n 5 7 and data are compiled from two experiments. splenocytes of S1P 1 GFP signalling mice and stimulation of Stat5 or Erk1/2 phosphorylation in splenocytes. a, Relative expression levels of S1pr1 mRNA in LSK and CLP cells from bone marrow, or splenic B or T cells of wild-type mice relative to mouse endothelial cells, as determined by multiplex qRT-PCR. Bars represent means and circles represent values obtained from individual mice. b, Representative histograms of GFP expression by LSK cells from bone marrow of S1P 1 GFP signalling mice (S1P1GS; green) or control (black) mice. c, Representative histogram of GFP expression by splenic B cells (CD19 1 ) from S1P 1 GFP signalling mice (green) or control (black) mice, demonstrating high in vivo GFP expression. d, Representative immunofluorescence image of IL-7Ra 1 cell with CLP morphology from bone marrow of littermate control of S1P 1 GFP signalling mice. Cells were subjected to the same selection process before immunofluorescence staining. d-f, IL-7Ra, red; blue, DAPI. e, f, Staining of bone marrow cells from S1P 1 GFP signalling mouse littermate controls demonstrates IL-7Ra staining specificity: cells with CLP morphology stained with secondary alone (e) or myeloid cell morphology from bone marrow stained with anti-IL-7Ra (f) exhibit no IL-7Ra positivity. g, p-Stat5 staining after in vitro stimulation of wild-type splenocytes with IL-7 (10 ng ml 21 ) for 15 min. CD19 1 cells serve as positive controls for p-Stat5 staining. CD11b 1 cells serve as negative controls, since they do not have IL-7R and therefore do not respond to IL-7 stimulation with Stat5 phosphorylation. h, p-Erk1/2 staining after in vitro stimulation of wild-type splenocytes with PMA (5 ng ml 21 ) for 15 min. CD19 1 cells serve as positive controls for p-Erk1/2 staining. HDL generates B cells at different stages of development. a, Phenotyping of B220 1 cell populations generated from wild-type (WT) Lin 2 bone marrow after 8 days of culture in methylcellulose medium. Initially, cells were gated as B220 2 , B220 1 , or B220 hi . From populations expressing B220, pro-B cell (Hardy fractions B/C) and pre-B cell (Hardy fraction D) equivalents were identified. Pro-B cells were defined as IL-7R hi , CD19 1 , cKit 1 , CD43 1 and IgM 2 . Pre-B cells were defined as IL-7R 1 , CD19 1 , cKit 2 , CD43 2 and IgM 2/lo . b, Western blot analysis of two batches of mouse HDL (batches n1 and n2) isolated from wild-type or Apom 2/2 mice showing the absence of contaminating albumin. c, LC-MS/MS analysis of HDL isolated from pooled plasmas of wild-type or Apom 2/2 mice. *P , 0.05, **P , 0.005. n 5 3. dhSph, dihydrosphingosine; dhS1P, dihydro-sphingosine-1-phosphate; Sph, sphingosine. LETTER RESEARCH
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